Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-99
SponsorUniversity Hospital, Toulouse
About this trial
The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies
Eligibility criteria
Qualifiers
Patients with rare systemic autoimmune diseases (lupus, scleroderma, myositis for example),
Patients with atypical presentations of documented or probable systemic autoimmune diseases,
Patients receiving, or likely to receive new, innovative therapies (new molecule on the market, gene therapy, cell therapy, etc.).
Disqualifiers
Known anemia and hemoglobin <10 g / dl
Patients under protective supervision (guardianship, curators)
Pregnant or breastfeeding woman
Trial design
Treatments tested in this trial
- Blood sampling
Treatment groups
3,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov